by Automated CPR devices utilize the principles of cardiopulmonary resuscitation (CPR) to provide chest compressions to patients suffering from cardiac arrest. These devices deliver consistent compressions that mimic manual CPR but with greater force and consistency. Automated CPR devices are commonly used in hospitals and pre-hospital settings to assist healthcare professionals in reviving patients. Key benefits of automated CPR devices include consistency in rate and depth of compressions compared to manual CPR. This helps improve blood flow to vital organs and increases survival rates.
The global Automated CPR Devices Market is estimated to be valued at US$ 127.6 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The growing incidence of cardiac arrest cases globally is a major driver for the automated CPR devices market. According to the American Heart Association, over 350,000 out-of-hospital cardiac arrests occur each year in the U.S. alone. Moreover, technological advancements incorporated in newer automated CPR devices which improve their efficiency in delivering accurate chest compressions is also fueling their adoption. However, high costs associated with automated CPR devices limits their widespread use, especially in budget constrained settings. To counter this, manufacturers are developing low-cost automated CPR devices to expand access in developing regions.
Segment Analysis
The global automated CPR devices market is dominated by pneumatic piston devices segment. These devices are easy to use, portable and offer consistent chest compressions compared to other devices. They are suitable for use in emergency situations and by first responders in the field as they do not require electricity to operate.
PEST Analysis
Political: Regulations regarding use of medical devices and user training are important from approval and adoption perspective. Favorable regulations support market growth.
Economic: Growing healthcare spending on critical care equipment and rise in disposable incomes boost market growth. However, high device costs can hinder broader adoption.
Social: Growing incidence of cardiac arrests and emphasis on public access defibrillation programs create demand. However, social stigma around CPR discourage bystander interventions.
Technological: Continuous innovation to develop devices offering consistent, effective chest compressions without user fatigue. Integration of sensors for monitoring patient vitals aids clinical decision making.
Key Takeaways
The global Automated CPR Devices Market Size is expected to witness high growth, exhibiting CAGR of 11% over the forecast period, due to increasing focus on public access defibrillation programs and delivery of global resuscitation guidelines recommending routine use of these devices.
North America dominates the market owing to growing awareness about importance of early CPR, availability of advanced healthcare infrastructure and presence of major players. The Asia Pacific market is expected to grow at fastest pace due to rising cases of cardiac arrests, growing focus of government on emergency cardiovascular care and increasing healthcare spending in the region.
Key players operating in the automated CPR devices market are ZOLL Medical Corporation, Stryker, Brunswick MedTech, Michigan Instruments, SunLife Sciences Pvt Ltd., CPR Medical Devices, Inc., Medtronic, Faith Group, Nihon Kohden Corporation, and SCHILLER Americas Inc. ZOLL leads the market with its robotic CPR device and growing focus on manufacturing lower-cost devices to make them accessible in low and middle-income countries.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
